Van Tibolli, LLC., dba GK Hair
Letter data
- Company
- Van Tibolli, LLC., dba GK Hair
- Recipient
- Mr. Van Tibolli | CEO | Van Tibolli, LLC., dba GK Hair | 1607 Ave. Ponce de Leon | San Juan | , | PR | 00909-1820 | United States | van.tibolli@VTBeauty.com
- Issue date
- 2020-05-26
- Posted date
- Not available
- FDA office
- Office of Human and Animal Food Operations Division IV East
- Subject
- Not available
- Product
- Dietary Supplements
- CMS ID
- 451478
- Reference number
- 20-HAFE4-WLCOL-08
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Van Tibolli, LLC., dba GK Hair
MARCS-CMS 451478 —
May 26, 2020
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Reference #:
20-HAFE4-WLCOL-08
Product:
Dietary Supplements
Recipient:
Recipient Name
Mr. Van Tibolli
Recipient Title
CEO
Van Tibolli, LLC., dba GK Hair
1607 Ave. Ponce de Leon
San Juan
,
PR
00909-1820
United States
van.tibolli@VTBeauty.com
Issuing Office:
Office of Human and Animal Food Operations Division IV East
United States
(787) 729-8500
Dear Mr. Tibolli:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to Warning Letter, FLA 15-31 dated September 2, 2015. It appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from your responsibility of assuring that your establishment is in compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. If you have any questions, contact Pearl Lopina, Compliance Officer at
407-475-4730
or
pearl.lopina@fda.hhs.gov
.
Kind regards,
/S/
Edwin Ramos
Director of Compliance Branch
OHAFO Division IV East
Content current as of:
05/26/2020
Regulated Product(s)
Dietary Supplements